U.S. flag

An official website of the United States government

NM_006005.3(WFS1):c.1495C>T (p.Leu499Phe) AND Monogenic diabetes

Germline classification:
Benign (1 submission)
Last evaluated:
Jan 11, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000664089.5

Allele description [Variation Report for NM_006005.3(WFS1):c.1495C>T (p.Leu499Phe)]

NM_006005.3(WFS1):c.1495C>T (p.Leu499Phe)

Gene:
WFS1:wolframin ER transmembrane glycoprotein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4p16.1
Genomic location:
Preferred name:
NM_006005.3(WFS1):c.1495C>T (p.Leu499Phe)
HGVS:
  • NC_000004.12:g.6301290C>T
  • NG_011700.1:g.36441C>T
  • NM_001145853.1:c.1495C>T
  • NM_006005.3:c.1495C>TMANE SELECT
  • NP_001139325.1:p.Leu499Phe
  • NP_005996.2:p.Leu499Phe
  • LRG_1417t1:c.1495C>T
  • LRG_1417:g.36441C>T
  • LRG_1417p1:p.Leu499Phe
  • NC_000004.11:g.6303017C>T
  • c.1495C>T
  • p.L499F
Protein change:
L499F
Links:
dbSNP: rs114152068
NCBI 1000 Genomes Browser:
rs114152068
Molecular consequence:
  • NM_001145853.1:c.1495C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006005.3:c.1495C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000787541Personalized Diabetes Medicine Program, University of Maryland School of Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)		Benign
(Jan 11, 2019) 		unknownresearch

PubMed (1)
[See all records that cite this PMID]

type2diabetesgenetics.org

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknown4not providednot providednot providednot providedresearch

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Personalized Diabetes Medicine Program, University of Maryland School of Medicine, SCV000787541.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedresearch PubMed (1)

Description

ACMG criteria: BA1 (2.5% in gnomAD Africans), BS2 (equal cases and controls in T2DM and 3 homozygotes in gnomAD) (REVEL 0.229 + PP3/3 predictors + BP4/6 predictors= conflicting evidence, not using)=benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot provided4not providednot providednot provided

Last Updated: Apr 15, 2024